The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion ofgsp−somatotropinomas

Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor

(2015) A. Karpathakis et al.   CLINICAL CANCER RESEARCH

Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas

(2015) Cristina L Ronchi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Multiple aberrant hormone receptors in Cushing's syndrome

(2015) Nada El Ghorayeb et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

ARMC5Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences

(2015) Stéphanie Espiard et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pregnancy, Primary Aldosteronism, and Adrenal CTNNB1 Mutations

(2015) Ada E.D. Teo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysis

(2015) Z. A. Efstathiadou et al.   Pituitary

Foxa1 and Foxa2 Regulate α-Cell Differentiation, Glucagon Biosynthesis, and Secretion

(2014) Mounia Heddad Masson et al.   ENDOCRINOLOGY

Activation of the Dopamine Receptor Type-2 (DRD2) Promoter by 9-Cis Retinoic Acid in a Cellular Model of Cushing's Disease Mediates the Inhibition of Cell Proliferation and ACTH Secretion Without a Complete Corticotroph-to-Melanotroph Transdifferentiation

(2014) Gianluca Occhi et al.   ENDOCRINOLOGY

Acromegaly: An Endocrine Society Clinical Practice Guideline

(2014) Laurence Katznelson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A Naturally Occurring GIP Receptor Variant Undergoes Enhanced Agonist-Induced Desensitization, Which Impairs GIP Control of Adipose Insulin Sensitivity

(2014) S. Mohammad et al.   MOLECULAR AND CELLULAR BIOLOGY

Mutations in the deubiquitinase gene USP8 cause Cushing's disease

(2014) Martin Reincke et al.   NATURE GENETICS

β-Arrestin 1 and 2 and G Protein-Coupled Receptor Kinase 2 Expression in Pituitary Adenomas: Role in the Regulation of Response to Somatostatin Analogue Treatment in Patients With Acromegaly

(2013) Federico Gatto et al.   ENDOCRINOLOGY

Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors

(2013) Scott K. Sherman et al.   SURGERY

Pax6 Is a Key Component of Regulated Glucagon Secretion

(2012) Yvan Gosmain et al.   ENDOCRINOLOGY

The Glucose-Dependent Insulinotropic Polypeptide Receptor is Overexpressed Amongst GNAS1 Mutation-Negative Somatotropinomas and Drives Growth Hormone (GH)-Promoter Activity in GH3 Cells

(2011) G. Occhi et al.   JOURNAL OF NEUROENDOCRINOLOGY

Regulation of gonadotropin-releasing hormone neurons by glucose

(2011) Alison V. Roland et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors

(2010) Mi Jin Moon et al.   MOLECULES AND CELLS

GIP and GLP-1, the two incretin hormones: Similarities and differences

(2010) Yutaka Seino et al.   Journal of Diabetes Investigation

Acromegaly

(2009) Philippe Chanson et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Acromegaly pathogenesis and treatment

(2009) Shlomo Melmed   JOURNAL OF CLINICAL INVESTIGATION

Pax6 and Pdx1 are required for production of glucose-dependent insulinotropic polypeptide in proglucagon-expressing L cells

(2008) Yukihiro Fujita et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM